Evidence map›Paper›PMID 38801073›Full record

ArticleNucleic acids research2024

The TIMELESS and PARP1 interaction suppresses replication-associated DNA gap accumulation.

Joanne Saldanha, Julie Rageul, Jinal A Patel, Amy L Phi, Natalie Lo, Jennifer J Park, Hyungjin Kim

Abstract read
In one paragraph

Article in Nucleic acids research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. PARP1-mediated 5' flap dynamics facilitate Okazaki fragment maturation.bioRxiv : the preprint server for biology · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Research square · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. The Influence of Circadian Rhythms on DNA Damage Repair in Skin Photoaging.International journal of molecular sciences · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Joanne SaldanhaDepartment of Pharmacological Sciences, State University of New York at Stony Brook, Stony Brook, NY 11794, USA.ORCID 0000-0002-1419-0859
Julie RageulDepartment of Pharmacological Sciences, State University of New York at Stony Brook, Stony Brook, NY 11794, USA.
Jinal A PatelDepartment of Pharmacological Sciences, State University of New York at Stony Brook, Stony Brook, NY 11794, USA.
Amy L PhiDepartment of Pharmacological Sciences, State University of New York at Stony Brook, Stony Brook, NY 11794, USA.
Natalie LoDepartment of Pharmacological Sciences, State University of New York at Stony Brook, Stony Brook, NY 11794, USA.
Jennifer J ParkDepartment of Pharmacological Sciences, State University of New York at Stony Brook, Stony Brook, NY 11794, USA.
Hyungjin KimDepartment of Pharmacological Sciences, State University of New York at Stony Brook, Stony Brook, NY 11794, USA.ORCID 0000-0003-1913-6373

Funding

The interplay of TIMELESS and PARP1 in DNA replication fork stabilityR01GM144399 · NIGMS · STATE UNIVERSITY NEW YORK STONY BROOK · PI KIM, HYUNGJIN · 2022 to 2025
$1.4M
Scholars in BioMedical Sciences (SBMS) Training ProgramT32GM127253 · NIGMS · STATE UNIVERSITY NEW YORK STONY BROOK · PI TSIRKA, STYLIANI-ANNA (STELLA) E · 2018 to 2022
$689k
Pathways of oncogene-induced senescence at DNA replication forksF31CA278156 · NCI · STATE UNIVERSITY NEW YORK STONY BROOK · PI PARK, JENNIFER · 2023 to 2025
$123k
American Cancer Society RSG-18-037-DMCAmerican Cancer Society Institutional ResearchBreast Cancer AllianceNCI NIH HHS F31 CA278156NIGMS NIH HHS R01 GM144399NIGMS NIH HHS T32 GM127253NIH HHS F31CA278156NIH HHS R01GM144399
6 · The paper itself

Abstract

TIMELESS (TIM) in the fork protection complex acts as a scaffold of the replisome to prevent its uncoupling and ensure efficient DNA replication fork progression. Nevertheless, its underlying basis for coordinating leading and lagging strand synthesis to limit single-stranded DNA (ssDNA) exposure remains elusive. Here, we demonstrate that acute degradation of TIM at ongoing DNA replication forks induces the accumulation of ssDNA gaps stemming from defective Okazaki fragment (OF) processing. Cells devoid of TIM fail to support the poly(ADP-ribosyl)ation necessary for backing up the canonical OF processing mechanism mediated by LIG1 and FEN1. Consequently, recruitment of XRCC1, a known effector of PARP1-dependent single-strand break repair, to post-replicative ssDNA gaps behind replication forks is impaired. Physical disruption of the TIM-PARP1 complex phenocopies the rapid loss of TIM, indicating that the TIM-PARP1 interaction is critical for the activation of this compensatory pathway. Accordingly, combined deficiency of FEN1 and the TIM-PARP1 interaction leads to synergistic DNA damage and cytotoxicity. We propose that TIM is essential for the engagement of PARP1 to the replisome to coordinate lagging strand synthesis with replication fork progression. Our study identifies TIM as a synthetic lethal target of OF processing enzymes that can be exploited for cancer therapy.

Indexed as

Cell Cycle ProteinsDNA ReplicationDNA, Single-StrandedIntracellular Signaling Peptides and ProteinsPoly (ADP-Ribose) Polymerase-1DNADNA-Binding ProteinsDNA Ligase ATPDNA RepairFlap EndonucleasesHumansX-ray Repair Cross Complementing Protein 1Cell Cycle ProteinsDNADNA-Binding ProteinsDNA Ligase ATPDNA, Single-StrandedFEN1 protein, humanFlap EndonucleasesIntracellular Signaling Peptides and ProteinsLIG1 protein, humanOkazaki fragmentsPARP1 protein, humanPoly (ADP-Ribose) Polymerase-1TIMELESS protein, humanX-ray Repair Cross Complementing Protein 1XRCC1 protein, human

Identifiers

PMID38801073
PMCPMC11194094

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.